SC
CL icon

Sapient Capital’s Colgate-Palmolive CL Stock Holding History

Sapient Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$614K Buy
7,197
+688
+11% +$62.3K 0.01% 239
2026
Q2 		$597K Sell
6,509
-293
-4% -$25.6K 0.01% 250
2026
Q1 		$580K Sell
6,802
-1,707
-20% -$152K 0.01% 252
2025
Q4 		$677K Sell
8,509
-1,255
-13% -$98.4K 0.01% 235
2025
Q3 		$785K Hold
9,764
– – 0.01% 222
2025
Q2 		$888K Buy
9,764
+162
+2% +$14.8K 0.02% 200
2025
Q1 		$900K Sell
9,602
-388
-4% -$34.7K 0.02% 200
2024
Q4 		$908K Buy
9,990
+157
+2% +$15K 0.02% 192
2024
Q3 		$1.02M Hold
9,833
– – 0.02% 190
2024
Q2 		$954K Buy
9,833
+35
+0.4% +$3.23K 0.02% 176
2024
Q1 		$882K Hold
9,798
– – 0.02% 187
2023
Q4 		$781K Buy
+9,798
New +$737K 0.02% 196

Other funds holding CL

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
BST
Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Sapient Capital's CL Position: Q3 2026 in Review

Sapient Capital increased its Colgate-Palmolive (CL) stake by 11% in Q3 2026, buying an estimated $62.3K and bringing the position to 7,197 shares worth $614K. The position accounts for 0.01% of the portfolio, ranked #239.

Sapient Capital first reported a position in CL in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.02M in Q3 2024. 106 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Sapient Capital held 7,197 shares of Colgate-Palmolive worth $614K as of Q3 2026.
  • Sapient Capital bought 688 Colgate-Palmolive shares in Q3 2026, an estimated $62.3K.
  • Colgate-Palmolive made up 0.01% of Sapient Capital's portfolio in Q3 2026, its #239 holding.
  • Sapient Capital first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 12 quarters since.
  • Sapient Capital's Colgate-Palmolive position peaked at $1.02M in Q3 2024.
  • 106 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.